Nanalysis Scientific (NSCI) Q2 2025 (Q&A) earnings summary

Executive summary

• Second quarter 2025 financial results were disappointing, with revenue at $9.6M, down 17% year-over-year due to lower product sales amid global economic uncertainty and tariff risks.

• Security services revenue increased 7% year-over-year, partially offsetting the decline in product sales.

• Optimism at the start of 2025 was based on a strong Q4 2024 and a full sales pipeline, but market uncertainty led to stalled orders.

• Restructuring and right-sizing efforts continue, aiming for sustainable profitability and operational execution.

• Cost reduction and efficiency measures improved gross margins in scientific equipment and security services.

Financial highlights

• Q2 2025 consolidated revenue: $9.6M, down $1.9M or 17% from Q2 2024.

• Gross margin on product sales rose to 61% from 50% year-over-year; security services margin steady at 10%.

• Adjusted EBITDA loss of $462K in Q2 2025, compared to a $759K profit in Q2 2024.

• Net loss for Q2 2025 was $2.1M, $127K higher than Q2 2024, mainly due to lower scientific equipment sales.

• Six-month revenue ended June 30, 2025: $20.2M, down 11% year-over-year; product sales fell 31%, security services up 7%.

Outlook and guidance

• Confidence expressed for a strong second half of 2025, with expectations of a good third quarter as stalled orders resume.

• Management expects continued margin improvement in security services through process and logistics enhancements.

• Focus remains on efficiency, margin improvement, and advancing core product and service offerings.

• Anticipated continued improvement in gross margins, especially if supply chain cost reductions are realized.

• Focus on achieving sustainable positive EBITDA and higher revenue.